Literature DB >> 1382313

Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor.

A Yanagisawa-Miwa1, Y Uchida, F Nakamura, T Tomaru, H Kido, T Kamijo, T Sugimoto, K Kaji, M Utsuyama, C Kurashima.   

Abstract

Coronary collateral vessels reduce damage to ischemic myocardium after coronary obstruction. Factors that stimulate collateral formation are expected to have ameliorating effects on myocardial infarction. In a canine experimental myocardial infarct model, intracoronary injection of basic fibroblast growth factor (bFGF) improved cardiac systolic function and reduced infarct size. Treatment with bFGF increased the number of arterioles and capillaries in the infarct. Thus, the angiogenic action of bFGF might lead to a reduction in infarct size. The application of bFGF might bring about a therapeutic modality for the salvage of infarcted myocardium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382313     DOI: 10.1126/science.1382313

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  76 in total

1.  Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.

Authors:  T Murohara; H Ikeda; J Duan; S Shintani; K i Sasaki; H Eguchi; I Onitsuka; K Matsui; T Imaizumi
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Therapeutic Angiogenesis for Coronary Artery Disease.

Authors:  Tanveer A. Khan; Frank W. Sellke; Roger J. Laham
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-02

3.  Tissue repair driven by two different mechanisms of growth factor plasmids VEGF and NGF in mice auricular cartilage: regeneration mediated by administering growth factor plasmids.

Authors:  Katarina Kolostova; Oliver Taltynov; Daniela Pinterova; Martin Cegan; Lenka Ceganova; Marie Jirkovska; Vladimir Bobek
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-10       Impact factor: 2.503

Review 4.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments.

Authors:  Kangwon Lee; Eduardo A Silva; David J Mooney
Journal:  J R Soc Interface       Date:  2010-08-18       Impact factor: 4.118

5.  Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.

Authors:  G Montrucchio; E Lupia; A de Martino; E Battaglia; M Arese; A Tizzani; F Bussolino; G Camussi
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

6.  Method for inducing the growth of new arteries in the myocardium.

Authors:  Yasuharu Noishiki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-08

7.  Long-term Angiogenesis Efficacy Using a Heparin-Conjugated Fibrin (HCF) Delivery System with HBM-MSCs.

Authors:  Ae-Kyeong Kim; Min-Hee Kim; Byung-Soo Kim; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2012-05       Impact factor: 2.500

8.  Platelet-derived growth factor BB induces functional vascular anastomoses in vivo.

Authors:  D M Brown; S P Hong; C L Farrell; G F Pierce; R K Khouri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

9.  Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury.

Authors:  R R Padua; R Sethi; N S Dhalla; E Kardami
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

10.  Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1α/IL-8 expression.

Authors:  Wen-Ching Shen; Chan-Jung Liang; Vin-Cent Wu; Shu-Huei Wang; Guang-Huar Young; I-Rue Lai; Chung-Liang Chien; Seu-Mei Wang; Kwan-Dun Wu; Yuh-Lien Chen
Journal:  Stem Cells Dev       Date:  2013-02-15       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.